Apollo Hospitals Enterprise Limited — Important, 10-02-2025: Financial Result Updates

**Apollo Hospitals Q3 FY25 Financial Summary**

Apollo Hospitals reported a solid performance in Q3 FY25, with consolidated revenues rising 14% YoY to ₹5,527 crores. This growth is attributed to robust demand across its healthcare services, particularly in specialized segments such as cardiac and oncology care.

Net profit for the quarter surged 52% YoY to ₹372 crores, reflecting effective cost management and operational efficiencies. The Earnings Per Share (EPS) reached ₹25.89, showcasing significant year-over-year improvement. The company's EBITDA also witnessed a healthy increase of 24% YoY, reaching ₹762 crores, driven by increased patient volumes and strategic investments in healthcare infrastructure.

Operational costs experienced a notable uptick mainly due to expansion efforts and the impact of inflation on materials and labor. However, the overall operational margins have remained stable, indicating effective cost control measures in place.

The balance sheet reflects a strong financial position, emphasizing a healthy cash flow that supports ongoing expansion plans, including the addition of 3,512 beds over the next few years. The positive cash position indicates potential for sustained growth and investment in advanced healthcare technologies and services.

In summary, Apollo Hospitals' strategic focus on enhancing service capabilities and operational efficiency reinforces its position in a growing healthcare market. Given the strong financial performance and future growth initiatives, a buy insight may be considered for investors looking at long-term value.